ISSN: 2755-0184 | Open Access

Journal of Diabetes Research Review & Reports

Prevalence and Associated Risk Factors of Peripheral Neuropathy in Diabetic Patients Attending the Primary Health Care Centers in Khartoum locality, Khartoum State, Sudan at 2019

Author(s): Nidal Abdelgadir Elbala Elmagboul

Abstract

Aim: assessing the prevalence of diabetic peripheral neuropathy and its associated risk factors in diabetic patients attending primary health care centers in Khartoum locality, Sudan 2019.


Materials and Method: Descriptive cross-sectional facility-based study, 288 patients were assessed using a questionnaire consist of two-part: the first part is regarding the sociodemographic data and the second part is a standardized MNSI questionnaire.


Results: out of 288 patients 223 were females, the mean age was 53.2 (SD ± 9.9 years), the majority had type 2 DM (98.6%). The overall prevalence of DPN was 42%, males were 31.4% and females were 68.4%. The risk factors for peripheral neuropathy were the female gender, the age of the patient more than 58 years and the duration of diabetes more than 10 years, smoking, being married and divorced, being overweight, being a householder, using oral hypoglycaemic agents, and being on poor glycaemic control with a p-value of 0.002, 0.001, 0.001, 0.012, 0.001, 0.001, 0.001, 0.024 and 0.001 respectively. In the logistic regression model the bad glycaemic control and the marital status (being married) emerged as significant independent predictors for developing DPN.


No significant association was found with the educational level of the patients (p-value = 0.127) and type of diabetes mellitus (p-value = 0.178).


Conclusion: high prevalence of peripheral neuropathy in diabetic patients attending primary health care center. Higher age, longer duration of diabetes, using oral hypoglycaemic agents, and poor glycaemic control were important risk factors for it

Introduction

Peripheral neuropathy is one of the most common complications of both type 1 and type 2 diabetes and the greatest source of morbidity and mortality in diabetes patients. Peripheral neuropathy (or diabetic polyneuropathy) can present as a loss of sensation that can lead to neuropathic ulcers, and it is a leading cause of amputation [1,2]. It is the most common type of neuropathy in people with diabetes [3,4]. Peripheral neuropathy may be asymptomatic. When symptoms are present, they may be negative or positive. Negative symptoms include loss of sensation and loss of strength, while positive symptoms include pricking or pain [4]. One of the most distressing symptoms that people can suffer from is a neuropathic pain and paraesthesia and this can severely impair the quality of life [1].

In a population-based study [5], 22% of the diabetic cohort had peripheral neuropathy that was graded as either moderate or severe. Long-standing peripheral neuropathic pain associated with peripheral neuropathy occurs in one of six diabetic subjects [6]. It is estimated that the prevalence of peripheral polyneuropathy in diabetes patients is approximately 25-50% in developing countries [7,8]. A DPN account for more hospital admissions than all other diabetic complications combined and is responsible for 50 - 75% of non-traumatic amputations [8,9]. Painful DPN is associated with a high degree of functional impairment, impairment in health-related quality of life, and activities of daily living [10,11]. Painful DPN reportedly results in significantly higher healthcare costs when compared with age and sex-matched diabetic patients without DPN [12,13]. Considering the priority of the problem and its increasing co-morbid complication, there is an undeniable need to prepare primary data for more awareness of stakeholders and better policy recommendations [14]. To address this issue, we should provide comprehensive scientific evidence that supports policy actions, program monitoring, and intervention evaluation [15]. This study aimed to assess the prevalence of DPN in diabetic centers in the Khartoum state.

Peripheral neuropathy is the most common risk factor for foot ulcers in diabetic patients contributing to higher than 80% ofthese ulcers [16,17]. Although diabetic foot is a quite common complication among diabetics, it is frequently ignored [18], a condition which is not only associated with high costs of treatment and care due to its prolong the length of hospitalization stay and increase risk of amputation but also places a heavy burden on the society [19]. Reports have revealed that neuropathy, diabetic foot, and amputation account for some 18% of the overall burden - calculated using Disability Adjusted Life Years (DALYs)- placed on Iran in 2001 [20]. The prevalence rate of diabetic foot in the world is about 3% [20]. Accordingly, statistics show that a diabetic somewhere in the world loses his/her leg every thirty seconds [21]. The foot ulceration is not only the most common complication of neuropathy but also among the preventable diabetes complications [19]. Identifying at-risk patients, hence, can preclude the development of a large number of foot ulcerations. The objectives of this study is to estimate the prevalence of diabetic peripheral neuropathy, to assess the risk factor of diabetic peripheral neuropathy and to assess the association between diabetic peripheral neuropathy and the risk factors that will help to provide primary data for more awareness of stakeholders and better policy recommendations.

Methods and Materials

This study was a multicenter, cross-sectional study conducted in PHC centers in Khartoum locality, Khartoum state, Sudan. The three PHC centers were selected randomly and two hundred eighty-eight diabetic patients were involved. Eligible were adults over 18 years who were diagnosed as type 1 or 2 diabetes mellitus. We exclude individuals with other neurological or pain conditions not associated with DPN. Ethical approval had been taken from the Department of Community Medicine, University of Khartoum, Sudan. Permission had been taken from the federal ministry of health, Sudan. Approval had been taken from Michigan university to use the MNSI questionnaire.

After taking written informed consent an interview-based questionnaire was administered to each of the participants in a homogenous manner to limit interviewer biases. The questionnaire was consisting of two-part: The first part is regarding the sociodemographic data of the patients including the age, gender, marital status, occupation, residence, education, type of diabetes, duration of diabetes, and type of treatment using and measuring height and weight to calculate BMI and measuring the HbA1C. The second part is the MNSI questionnaire which is a structured questionnaire compose of two-part the first part is to assess the symptoms of PN of the participants and a participant who answered positively will shift to the second part which is the clinical examination; examination of the feet appearance for dry skin, calluses, fissures or ulcers, infection and the evaluation of the fine touch using 10 g monofilaments vibration sensation be the tuning fork and ankle reflex by hummer. A diagnosis of DPN established be prior validation studies is >2 out of a total score of 8 in the MNSI questionnaire.
Data was Analysed partly manually and mostly by using SPSS software (version 21), it had been entered and encoded by the researcher and then frequencies of the sociodemographic variables had been calculated, the prevalence of peripheral neuropathy had been calculated and the association had been tested using T-test, chi-square test, and logistic regression. Final results were displayed and presented in the form of tables and graphs.

Results Socio-Demographic Characteristics

Out of 288 patients, 223 was females (77.4%) and 65 males (22.6%) [figure 1], the mean age was 53.2 (SD ± 9.9 years), the minimum age was 23 and the maximum was 73, the majority had type 2 DM (98.6%). Age distribution was found as follows: under 40 years were 24 represents 8.3%, 41-60 years were 176 represents 61.1% and 61, and above were 81 represents 28.1% [figure 2]. Regarding occupational background, housewives were 184 (63.9%), free workers were 22 (7.6%), employees were 41 (14.2%), retired were 12 (4.2%) and non-employed were 29(10.1%) [figure 3]. Regarding marital status singles were 6 represent 2.1%, married were 256 represent 88.9%, divorce was 3 represent 1% and widow was 23 represent 8% [figure 5]. Regarding educational levels primary school was 16 represents 5.6%, the secondary school was 144 represents 50% and higher education was 128 represents 44.4% [figure4].

img

Figure 1: The Percent’s of the gender of the diabetic patients attending PHC centers in Khartoum locality, Sudan

img

Figure 2: The Age of diabetic patients attending PHC centers in al Khartoum locality. (N=288)

img

Figure 3: The occupation of the diabetic patients attending PHC centers in al Khartoum locality. (N=288)

img

Figure 4: Educational level of the diabetic patients attending PHC centers in al Khartoum locality. (N=288)

img

Figure 5: Marital status of the diabetic patients attending PHC centers in al Khartoum locality. (N=288)

The Risk Factors of Diabetic Peripheral Neuropathy

The association between the peripheral neuropathy and its risk factors was assessed using a T-test for continuous data and chisquare test for categorical data and the results were as follow: There is a significant association between the DPN and the increase in the age of the patient more than 58 years (p-value = 0.001) and increase the duration of diabetes for more than 10 years (p-value = 0.001). there is a significant association with the female gender (p-value = 0.002) also there is a significant association with the occupation of the patients: DPN is more prevalent in householder followed by the non-employed patients (p-value =0.001). [table 3]

There is a significant association between DPN and marital status (p-value = 0.001). also, there is a significant association between DPN and overweight patients (p-value = 0.001). there is a significant association with the bad glycaemic control of the patient (p-value =0.001). There is a significant association with smoking (p-value = 0.012) and the type of treatment used by the patient (p-value = 0.024). [Table 3].
On the other hand, no significant association was found between the educational level of the patients (p-value = 0.127) and the type of diabetes mellitus (p-value = 0.178). [table 3]

Table 1: The prevalence of peripheral neuropathy in diabetic patients attending PHC centers in Khartoum locality, Khartoum state, Sudan 2019

DPN Frequency Percent
Present 121 42
Absent 167 58

Table 2: The association between DPN and the age of the patients and duration of DM in diabetic patients attending the PHC centers in Khartoum locality, Khartoum state, Sudan 2019

Mean SD P value
Age Present 56.8 9.8 0.001
Absent 50.6 9.2
Duration of DM Present 10.4 4.1 0.001
Absent 6.7 4.9

Table 3: The association between DPN and the risk factors in diabetic patients attending the PHC centers in Khartoum locality, Khartoum state, Sudan 2019

Risk factor Variables Diagnosis of peripheral neuropathy Total P value
Absent Present
Gender Male 27 38 65 0.002
Female 140 83 223
Occupation Employed 12 27 29
unemployed 35 6 41
Retired 4 8 12 0.001
Free worker 7 15 22
House holder 109 75 84
Educational level Primary school 7 9 16
Secondary school 78 66 144 0.127
Higher education 82 46 128
Marital status Single 2 4 6 0.001
Married 158 98 256
Divorce 2 1 3
Widow 5 18 23
Smoking Smoker 10 18 28 0.012
Non smoker 157 103 260
Type of diabetes Type 1 1 3 4 0.178
Type 2 166 118 284
Treatment used Hypoglycaemic agents 166 114 280 0.024
Insulin 1 3 4
Both 0 4 4
BMI Normal weight 30 45 75 0.001
Over weight 135 75 210
obese 2 1 3 0.001
HbA1c level Good control 131 61 192
Bad control 36 60 96

Testing Association Using the Adjusted Odd Ratio

In gender: the odd of men developing DPN was 0.5 times lower the odds of female developing DPN and the odd of a smoker to develop DPN is 0.63 times lower the odd of the non-smoker. Regarding occupation of the patients, the odd of employed patients developing DPN is 2 times higher the odd of the householder developing DPN, and the odd of non- employed, retired, and free worker developing DPN was 0.4, 0.26, and 0.27 times lower the odd of the householder developing DPN, respectively. [Table 4].

Regarding educational level, the odd of the patient with primary education developing DPN was 0.33 times lower the odd of patients with higher education, and the odd patients with secondary education were 0.49 times the odd of patients with higher education developing DPN. [Table 4].

Table 4: Logistic regression model to predict the development of peripheral neuropathy in diabetic patients attending PHC centers in Khartoum locality, Khartoum state, Sudan 2019

P Value OR 95%CI
Smoking .362 .633 237 - 1.692
Male .051 .510 .255 - 1.002
Employed 067 2.622 .933 - 7.368
Married .009 4.183 1.420 - 12.323
Divorce .323 4.345 237 - 79.835
Bad control .000 3.102 1.806 - 5.328
Over weight .474 .409

In the logistic regression model the bad glycaemic control and the marital status (being married) emerged as significant independent predictors for developing DPN (OR 3.102, 95% CI = 1.805-5.328, P = 0.001) and (OR=4.183, 95%CI=1.420 - 12.323, P=0.009) respectively

Regarding the type of diabetes mellitus, the odd of patients developing DPN was four times higher the odd of patients with type I DM developing DPN although there was no association (p-value = 0.178). The odd of Patients with normal weight and overweight developing DPN were 0.2 and 0.4 times lower the odd of obese patients developing DPN, respectively. [Table 4].

Discussion

This study showed a high prevalence of DPN 42% based on the MNSI questionnaire and 10 monofilament testing. A study conducted in Iran used the same method for diagnosing peripheral neuropathy and it concludes that the combination of MNSI questionnaire and monofilament test are the most accurate screening tool for diagnosing PN in diabetic patients. This high prevalence resembles a systemic review and metaanalysis conducted across Africa which showed that the overall prevalence of diabetic peripheral neuropathy was 46% [30,37]. The current study shows a high degree of DPN compared to other studies in Saudi Arabia 35% and this may be due to the method for diagnosing PN in this study which diagnosed using a questionnaire (Douleur Neuropathique 4) and there is other studies showed lower prevalence include: Jordan 39.5%, Europe 28%, Qatar 34.5% and UK 28.5%, the difference in prevalence across the different country may due to different study population, study design and different method for diagnosing PN in diabetic patients [28, 29, 39, 32, 36].

On the other hand, a very high degree of DPN is estimated in Tanzania 72.2% and this may be due to the area of study which was a tertiary hospital, and it’s more porn to recruit patients with complications than PHC centers on the current study. These different degrees of DPN are attributed to early diagnosis and proper case management as well as different geographical areas, different study populations, and different methods used to diagnose peripheral neuropathy in diabetic patients [34].
The current study shows that high prevalence of peripheral neuropathy associated with increased age with the mean age of developing PN was (56.8 ± 9.7) years of age and was 4.1% aged [20-40], 49.5% aged [41-59] and 46.2% [60-75] aged and the odd of patients aged [60-75] developing DPN is 9 times higher the odd of patients aged [20-40] developing DPN and the odd of patients aged [60-75] developing DPN is 3 times higher the odd of patients aged [41-59] developing DPN. This may be attributed to the fact that with the increase of age there is some degree of loss of some nerve fibers, results obtained from a study conducted by Peter A.

Also increase age consistent with increasing duration of diabetes which leads to an increase in the frequency of microvascular and macrovascular complications.

There is a high association with increased duration of diabetes with the mean duration found to be (10.4 ±4.1) years since diagnosis, which was consistent with many studies showed the same association but with different mean of age and duration of diabetes and this may be due to increasing duration increased the susceptibility for developing more complications of diabetes, in Qatar the mean age was (57.5 ±10.7) and the mean duration was (13.6 ± 7.9) and in Jorden, the mean of age was (57.8 ±9.7) and the mean duration of DM was (6 ±5.1), also multiple studies conducted in Italy and Iran showed the same association. In contrast, a study conducted in Saudi Arabia showed no association between the development of peripheral neuropathy and the age and duration of DM [28, 29].
Regarding the gender of the patients, this study shows a high association with the female gender (p-value =0.002) and this may be due to the body difference of the females; high lipid levels and it’s scientifically approved that the effect of high lipid resembles the effect of hyperglycaemia on the nerve damage. A unique study conducted in the USA in both type I and type II patients it showed that gender was associated with developing PN only in patients with type II DM with female predominance not in type I [33].

Regarding the occupation of the patients, the current study shows a high association with the occupation of the patients and it shows that being employed increase the risk of developing PN twofold than being a householder these may be due to increasing the stress due to workload but this farther studying to assess the type of work and the working hours. This was inconsistent with a study conducted in Jordan it showed that being unemployed increases the risk of developing PN.
The current study shows a significant association with the type of treatment for DM (p-value = 0.024) mainly using oral hypoglycaemic agents increase the risk of developing PN in diabetic patients that may be because hyperglycaemia causing microvascular and macrovascular complications this resembles a result obtained in a study conducted in Tanzania showed increasing the risk of developing PN with patients using oral hypoglycaemic agents [34].

Regarding smoking, this study shows an association between developing PN and smoking (p- value 0.012) and this may be due to the fact that smoking diminished blood supply to microvascular nerve cells and that will result in nerve damage. This result is consistent with a result obtained from a study conducted in the USA [high association in type I patients (p- value 0.001) and less association in type II patients (p-value 0.01)] and it’s inconsistent with results obtained from other two studies conducted in Saudi Arabia and Kuala Lumpur that showed no association. This association needs further assessment because the duration of smoking and the daily average cigarette consumption hadn’t been assessed [33].
This study shows a high association with glycaemic control of the patients (p-value 0.001) that being in a good control decrease the risk of developing PN (odd ratio=1.58), in contrast, different studies had shown no association with the HbA1C level include a study conducted in Iran, India, Kuala Lumpur, USA, and Qatar [27, 29, 30, 35, 39].

Another factor was the BMI of the patients and it was found to be highly associated with the development of PN (p-value 0.001) and Patients with normal weight and overweight were 20.7% and 40.9% less likely to develop PN than obese patients, respectively this may be since obesity impaired the glucose tolerance so worsen diabetes and hyperglycaemia which increase the risk of nerve damage. In contrast, a study conducted in the USA showed a high association with BMI in type I DM patients only (p-value 0.001) and no association in type II DM patients. Also, no association with it found in other studies conducted in Saudi Arabia, Iran, India, and Kuala Lumpur [27, 28, 30, 39].
The current study addressed two unique risk factors which are the educational level and the marital status and the results showed that there is a high association with the marital status (p- value 0.001) and it showed that married and divorce patients were four-fold more likely to develop PN than widow patients and single patients were 96% less likely to develop PN than widow patients this may be due to the small percent of widow patients in the study.
Regarding the educational level, no significant association is found between the development of PN and the educational level of the patients.

There is a limitation to this study. The sampling was not random so the generalizability of this study to the general population is restricted and the study type is cross-sectional which will not enable the researcher to assess the long term effect of the risk factors on the outcome. The study restricted patients come to PHC centers which are less likely to recruit patients with complications. Also, there may some technical errors during neurological examination but this is minimized by using the same person for all the examination. Another important limitation is the lack of assessment of hypertension and the lipid profile of the patients as being an important risk factor and the lack of assessment of other conditions that may lead to neurological problems like vitamin B12 and folic acid deficiency [22-26].

Conclusion

This study has identified a high prevalence of peripheral neuropathy in diabetic patients attending the primary health care centers in Khartoum locality. Another important finding in this study is the association of the development of DPN with female gender, increase age, increase duration of DM, BMI, poor glycaemic control indicated by HbA1C level, smoking, marital status especially being married and divorced, the occupation of the patient especially being employed and the medication used for DM especially using oral hypoglycaemic agents. On the other hand, the type of diabetes and the educational level not found to be associated with the development of peripheral neuropathy in diabetic patients [31, 32, 38 & 40].

Recommendations

This study finding could provide practical information for diabetic peripheral neuropathy for better health policy and basement for further researches.

Inform the decision-makers in government and the ministry of health about the seriousness of the situation and prepare a plan for setting health policies and developing a campaign to increase DM awareness, prevention, and management.

Making the neurological history and examination part of the routine visit of the diabetic patient. Intensive health education of the patients to be aware of the complication of DM and the way of prevention and that tight control of the glycaemic status can prevent neurological complications. Also the regular follow up can detect the early complication so further deterioration can be prevented.

Further studies in larger population size and with different diagnostic tools to check the accuracy and to evaluate the effect of more factors in the development of DPN.

Reference

  1. Poncelet AN (2003) Diabetic polyneuropathy: risk factors, patterns of presentation, diagnosis, and treatment (Review). Geriatrics 58: 16-18, 24-25, 30.
  2. Vileikyte L, Rubin RR, Leventhal H (2004) Psychological aspects of diabetic neuropathic foot complications: an overview. Diabetes Metab Res Rev 20: S13-S18.
  3. Melton LJ III, Dyck PJ (1999) Epidemiology. In Diabetic Neuropathy. 2nd ed. Dyck PJ, Thomas PK, Eds. Philadelphia, W.B. Saunders p.239-245.
  4. Melton LJ III, Dyck PJ (1999) Diabetic polyneuropathy. In Diabetic Neuropathy. 2nd ed. Dyck PJ, Thomas PK, Eds. Philadelphia, W.B. Saunders p. 255-278.
  5. Abbott CA, Carrington AL, Ashe H, Bath S, Every LC, et al. (2002) The North-West Diabetes Foot Care Study: incidence of, and risk factors for, new diabetic foot ulceration in a community-based patient cohort. Diabet Med 19: 377-384.
  6. Daousi C, MacFarlane IA, Woodward A, Nurmikko TJ, Bundred PE, et al. (2004) Chronic painful peripheral neuropathy in an urban community: a controlled comparison of people with and without diabetes. Diabet Med 21: 976-982.
  7. Vinik AI, Mehrabyan A (2004) Diabetic neuropathies. Med Clin North Am 88: 947-999.
  8. Harris M, Eastman R, Cowie C (1993) Symptoms of sensory neuropathy in adults with NIDDM in the US population. Diabetes Care 16: 1446-1452.
  9. Boulton AJ, Malik RA, Arezzo JC (2004) Diabetic somatic neuropathies. Diabetes Care 27: 1458-1486.
  10. Galer BS, Gianas A, Jensen MP (2000) Painful diabetic polyneuropathy: epidemiology, pain description, and quality of life. Diabetes Res Clin Pract 47: 123-128.
  11. Gordois A, Scuffham P, Shearer A, Oglesby A, Tobian JA (2003) The health care costs of diabetic peripheral neuropathy in the US. Diabetes Care 26: 1790-1795.
  12. Veves A, Backonja M, Malik RA (2008) Painful diabetic neuropathy: epidemiology, natural history, early diagnosis, and treatment options. Pain Med 9: 660-674.
  13. Barrett AM, Lucero MA, Le T, Robinson RL, Dworkin RH, et al. Epidemiology, public health burden, and treatment of diabetic peripheral neuropathic pain: a review. Pain Med 8: S50-S62.
  14. Mcbride T, Coburn A, Mackinney C, Mueller K, Slifkin R, et al. (2008) Bridging health research and policy: effective dissemination strategies. J Public Health Manag Pract 14: 150-154.
  15. Brownson RC, Jones E (2009) Bridging the gap: translating research into policy and practice. Prev Med 49: 313-315
  16. Murray HJ, Young MJ, Mollis S, Boulton AJ (1996) The association between callus formation, high pressures and neuropathy in diabetic foot ulceration. Diabet Med 13: 979- 83.
  17. Mc Neely MJ, Boyko EJ, Ahroni JH, Sensel VL, Reiber GE, et al. (1995) The independent contributions of diabetic neuropathy and vasculopathy in foot ulceration. How great are the risks? Diabetes Care 18: 216-19.
  18. Singh D (2006) Diabetic foot: It is time to share the burden. Calicut Med J 4: e 4.
  19. Khatib O, Tabatabaei Malazy O (2007) Prevention and public approach to diabetic foot. Iranian J of Diabetes & Lipid Disorders 7: 123-33.
  20. Abolhasani F, Mohajeri Tehrani MR, Tabatabaei Malazy O, Larijani B (2003) Burden of diabetes and its complications in Iran in Year 2000. Iranian J of Diabetes & Lipid Disorders, 5: 35-48.
  21. Calle- Pascual AL, Redondo MJ, Ballesteros M, Martinez Salinas MA, Diaz JA, et al. (1997). Non traumatic lower extremity amputations in diabetic and non- diabetic subjects in Madrid, Spain. Diabetes Metab 23: 519-23.
  22. Rahimi-saghand S (2014) Prevalence of Peripheral Neuropathy in Diabetic Patients 5: 107-13.
  23. Shiferaw WS, Yirga T, Work Y, Aynalem YA (2019) Prevalence of diabetic peripheral neuropathy in Africa: A systematic review and meta-analysis. BMC Endocrine Disorders 20: 49.
  24. Bakhsh E, Qutub S (2017) LEVELS AND BARRIERS OF GLYCEMIC CONTROL AND SELF-MANAGEMENT AMONG DIABETIC PATIENTS IN PRIMARY HEALTH CARE IN JEDDAH: A CROSS-SECTIONAL STUDY.
  25. International Journal of Advanced Research 5: 1721-1733.
  26. Ponirakis G, Elhadd T, Chinnaiyan S, Dabbous Z, Siddiqui M, et al. (2019) Prevalence and risk factors for painful diabetic neuropathy in secondary healthcare in Qatar 10: 1558-1564.
  27. Khawaja N, Abu-Shennar J, Saleh M, Dahbour S, Khader Y, et al. (2018) The prevalence and risk factors of peripheral neuropathy among patients with type 2 diabetes mellitus; the case of Jordan. Diabetology & Metabolic Syndrome 10: 8.
  28. Tesfaye S, Stevens LK, Stephenson JM, Fuller JH, Plater M, et al. (1996) Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM Complications Study. Diabetologia 39: 1377-84.
  29. M J Young, A J M Boulton, A F Macleod, D R R Williams, P H S onksen P H (1993) A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia 36: 150-154.
  30. Amour AA, Chamba N, Kayandabila J, Lyaruu IA, Marieke D, et al. (2019) Prevalence, Patterns, and Factors Associated with Peripheral Neuropathies among Diabetic Patients at Tertiary Hospital in the Kilimanjaro Region: Descriptive Cross- Sectional Study from North-Eastern Tanzania v.2019.
  31. Jaiswal M, Divers J, Dabelea D, Isom S, Bell RA, et al. (2017) Prevalence of and Risk Factors for Diabetic Peripheral Neuropathy in Youth with Type 1 and Type 2 Diabetes: SEARCH for Diabetes in Youth Study 40: 1226-32.
  32. Gill HK, Yadav SB, Ramesh V, Bhatia E (2014) A prospective study of prevalence and association of peripheral neuropathy in Indian patients with newly diagnosed type 2 diabetes mellitus. J Postgrad Med 60: 270-5.
  33. Davies M, Brophy S, Williams R, Taylor A (2006) The Prevalence, Severity, and Impact of Painful Diabetic Peripheral Neuropathy in Type 2 Diabetes. Diabetes Care 29: 1518-1522.
  34. Abbott CA, Carrington AL, Ashe H, Bath S, Every LC, et al. (2002) The North-West Diabetes Foot Care Study: incidence of, and risk factors for new diabetic foot ulceration in a community-based patient cohort. Diabet Med 19: 377-84.
  35. Poncelet AN (2003) Diabetic polyneuropathy: risk factors, patterns of presentation, diagnosis and treatment (Review). Geriatric 58: 16-8.
  36. Vilekyte L, Rubin RR, Leventhal H (2004) Psychological aspects of diabetic neuropathic foot complications: an overview. Diabetes Metab Res Rev 20: 13-8.
  37. Melton LJ III, Dyck PJ (1987) Epidemiology. In: Dyck PJ, Thomas PK, Asbury AK, Winegrad AI, Porte DJr. Diabetic neuropathy. Philadelphia, PA: Saunders; 1987: 27-35.
  38. Benbow SJ, Wallymahmed ME, Macfarlane IA (1998) Diabetic peripheral neuropathy and quality of life. J Med 91: 733-7.
  39. Tabatabaei-Malazy O, Mohajeri-Tehrani M, Madani S, Heshmat R, Larijani B (2011) The prevalence of diabetic peripheral neuropathy and related factors. Iran J Public Health. 40: 55-62.
  40. Hussein A, Nour GM, Sidig A, Hamad A (2009) The prevalence of neurological complications among Adult Sudanese diabetic patients 1: 4-7.
  41. Mimi O, Teng CL, Chia YC (2003) The prevalence of diabetic peripheral neuropathy in an outpatient setting. Med J Malaysia 58: 533-8
View PDF